Nanotechnology Now |
Home > Press > US Patent Grant Extends VivaGel(R) Coverage to 2024
 |
Abstract:
Starpharma Holdings Limited (ASX: SPL) today announced that it has received notification of the grant in the US of a key patent specifically relating to the use of SPL7013 to protect against sexually transmitted infections (STIs).
US Patent Grant Extends VivaGel(R) Coverage to 2024
Melbourne, Australia | Posted on September 22nd, 2009The granting of this patent means that any product presentation of SPL7013 (the active ingredient in VivaGel(R) ) is now protected in the US for an additional five years until 2024, with a possible further 12 month extension to 2025. Given the importance of genital herpes and other STIs in the US, this market is clearly a major commercial opportunity for VivaGel(R) products.
This composition of matter patent is the third patent for VivaGel(R) to be granted in the US, and adds to the already extensive patent coverage for the product in 26 countries covering all major markets.
VivaGel(R) is being developed as a condom coating in collaboration with SSL International plc (LSE: SSL) , the world's leading condom company. SSL markets the global brand Durex(R), and holds approximately 40% of the global branded condom market. Following a deal announced in 2008, SSL has exclusive marketing rights for the VivaGel(R) coated condom.
Starpharma is also developing VivaGel(R) as a vaginal microbicide to prevent the transmission of STIs, including HIV and genital herpes.
####
About Starpharma
Starpharma Holdings Limited (ASX: SPL) is a world leader in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications. SPL has two operating companies, Starpharma Pty Ltd in Melbourne, Australia and DNT, Inc in the USA.
The Company's lead pharmaceutical development product is VivaGel(R) (SPL7013 Gel), a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes. In September 2008 Starpharma signed a full licence agreement with SSL International plc (LSE: SSL) to develop a VivaGel(R) coated condom. Starpharma's receipts under the agreement are estimated to exceed A$100m comprising royalties on SSL sales, further milestone payments, and development support.
For more information, please click here
Contacts:
Media:
Buchan Consulting
Rebecca Wilson
Tel: +61 3 9866 4722
Mob: +61 417 382 391
Ellie Papathanasiou
Tel: +61 2 9237 2800
Starpharma:
Dr Jackie Fairley
Chief Executive Officer
+61 3 8532 2704
Ben Rogers
Company Secretary
+61 3 8532 2702
Copyright © PrNewswire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
IDTechEx launches online Market Intelligence Portal May 23rd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Products
International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013
Industrial Nanotech Launches Nansulate(R) Vinyl Fresh: Clear Liquid Thermal Insulation and UV Protection Coating Rejuvenates Vinyl Siding on Homes April 18th, 2013
MouthWatchers Nano-Silver Tooth Brush Released for Sale April 12th, 2013
Nanomedicine
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
Announcements
IDTechEx launches online Market Intelligence Portal May 23rd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Patents/IP/Tech Transfer/Licensing
Innovation could bring flexible solar cells, transistors, displays May 22nd, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
HELIOS Program Develops Complete Supply Chain for Integrating Photonics with CMOS Circuit via IC Fabrication Processes May 14th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013
Personal Care
New synthesis method produces nanoparticles in high quantities February 25th, 2013
Harris & Harris Group Notes Solazyme and Mitsui Multi-Year Agreement February 7th, 2013
X-rays reveal uptake of nanoparticles by soya bean crops: Metals contained in nanoparticles can enter into the food chain February 6th, 2013
Nature: super gel stiffens when heated January 23rd, 2013
Nanobiotechnology
Bacterial spare parts filter antibiotic residue from groundwater May 22nd, 2013
Researchers Perform Fastest Measurements Ever Made of Ion Channel Proteins May 20th, 2013
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||
abbigliamento uomo
Computer Accessories
| © Copyright 1999-2013 7th Wave, Inc. All Rights Reserved | PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE |